UNICANCER: Squamous Cell Carcinoma of Head and Neck trials

The registry lists 10 Squamous Cell Carcinoma of Head and Neck studies with UNICANCER as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal CancerNot yet recruitingNCT07241273Not applicable
• Blood Biomarkers Based Screening for HPV-driven OPCNot yet recruitingNCT06528353Not applicable
• SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal CancersRecruitingNCT05582122Phase 2
• Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck CancersRecruitingNCT04747054Phase 3
• Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPCCompletedNCT04725396Not applicable
• Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell CarcinomaTerminatedNCT04428047Phase 2
• Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsCompletedNCT04357873Phase 2
• Identifying the Predictive Factors of Response to PD-1 or PD-L1 AntagonistsTerminatedNCT03412058Not applicable
• Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN LossTerminatedNCT02822482Phase 1/2
• Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC PatientsCompletedNCT01415674Phase 2